A metagenome-wide association study of the gut microbiota in recurrent aphthous ulcer and regulation by thalidomide
Recurrent aphthous ulcer (RAU), one of the most common diseases in humans, has an unknown etiology and is difficult to treat. Thalidomide is an important immunomodulatory and antitumor drug and its effects on the gut microbiota still remain unclear. We conducted a metagenomic sequencing study of fec...
Main Authors: | Xiang Wang, Kexu Xiong, Fan Huang, Jinqun Huang, Qin Liu, Ning Duan, Huanhuan Ruan, Hongliu Jiang, Yanan Zhu, Lin Lin, Yuefeng Song, Maomao Zhao, Lichun Zheng, Pei Ye, Yajie Qian, Qingang Hu, Fuhua Yan, Wenmei Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1018567/full |
Similar Items
-
Systemic treatment in severe cases of recurrent aphthous stomatitis: an open trial
by: Maria Angela Martins Mimura, et al.
Published: (2009-03-01) -
Challenges in the diagnosis of periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome in developing countries—A decade of experience from North India
by: Aaqib Zaffar Banday, et al.
Published: (2022-09-01) -
Thalidomide in dermatology: Revisited
by: Iffat Hassan, et al.
Published: (2015-01-01) -
Thalidomide: from tragedy to promise
by: R Stolz
Published: (2003-02-01) -
Prevalence of Recurrent Aphthous Stomatitis in University Students and Its Relation with Anxiety
by: Atena Shiva, et al.
Published: (2019-12-01)